Prospects of developing interventions to prevent Alzheimer's disease

Pharmacotherapy

Volumn 18, Issue 2 II SUPPL., 1998, Pages

  Khachaturian, Zaven S ^a  

^a Radebaugh and Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E; HERBACEOUS AGENT; NEUROTRANSMITTER; PLANT EXTRACT; TAU PROTEIN; VITAMIN;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CELL COMMUNICATION; CELL DEATH; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 19; CHROMOSOME 21; EARLY DIAGNOSIS; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; GENE THERAPY; GENETIC PREDISPOSITION; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; REVIEW;

ALZHEIMER DISEASE; FORECASTING; HUMANS; RISK FACTORS;

EID: 0031891986     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
2. St. George-Hyslop PH, Tanzi RE, Polinksy RJ, et al The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Nature 1987;235:885-90.
3. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
4. Levy-Lehad E, Wasco W, Poorkaj P, et al. Candidate genes for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-7.
5. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-50.
6. Forster DP, Newens AJ, Kay DW, Edwardson JA. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health 1995;49:253-8.
7. Olichney JM, Sabbagh MN, Hofstetter CR, et al. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology 1997;49:76-81.
8. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 1997;17:6142-51.
9. Lindh M, Blomberg M, Jensen M, et al. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein. Neurosci Lett 1997;229:85-8.
10. Mark RJ, Blanc EM, Mattson MP. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 1996;12:211-14.
11. Imahori K, Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J Biochem 1997;121:179-88.
12. Coria F, Rubio I. Molecular mechanisms in Alzheimer's disease. Rev Neurol 1997;25(suppl 1):S50-4.
13. Muma NA, Singer SM. Aluminum-induced neuropathology: transient changes in microtubule-associated proteins. Neurotoxicol Teratol 1996;18:679-90.
14. Cuajungco MP, Lees GJ. Zinc and Alzheimer's disease: is there a direct link? Brain Res Rev 1997;23:219-36.
15. Kalaria RN, Harshbarger-Kelly M, Cohen DL, Premkumar DR. Molecular aspects of inflammatory and immune responses to Alzheimer's disease. Neurobiol Aging 1996;17:687-93.
16. Fox N, Freeborough PA, Rossor MN. Visualization and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-7.
17. Aksari P, Stoppe G. Risk factors in Alzheimer's dementia. Fortschr Neurol Psychiatr 1996;64:425-32.
18. Mayeux R, Ottman R, Maestre G, Ngai C, et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995;45:555-7.
19. Mortel KF, Meyer JS, Herod B, Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995;6:55-62.
20. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
21. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-8.